|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000046285 angiotensinogen, signal peptide removed form (human) | hAGT/SigPep- |
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051442 angiotensinogen N-glycosylated 1 (human) | hAGT/NGlyco:1 |
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051443 angiotensinogen N-glycosylated 2 (human) | hAGT/NGlyco:2 |
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051444 angiotensinogen N-glycosylated 3 (human) | hAGT/NGlyco:3 |
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051445 angiotensinogen N-glycosylated 4 (human) | hAGT/NGlyco:4 |
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051446 angiotensinogen N-glycosylated 5 (human) | hAGT/NGlyco:5 |
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051447 angiotensinogen N-glycosylated 6 (human) | hAGT/NGlyco:6 |
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051448 angiotensinogen O-glycosylated 1 (human) | hAGT/OGlyco:1 |
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-sequence
|
|
PR:P11859-1 angiotensinogen isoform 1 (mouse) | mAGT/iso:1 |
|
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-sequence
|
|
PR:P11859-1 angiotensinogen isoform 1 (mouse) | mAGT/iso:1 |
|
|
|
|
|
|
| | | | |
| | | | | | | |
modification
|
|
PR:000018931 angiotensinogen, signal peptide removed form | AGT/SigPep- |
|
|
|
|
|
|
| | | | | | |
| | | | | |
modification
|
|
PR:000018932 angiotensinogen proteolytic cleavage product | AGT/ClvPrd |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000046285 angiotensinogen, signal peptide removed form (human) | hAGT/SigPep- |
|
|
|
|